Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:14 AM
Ignite Modification Date:
2025-12-25 @ 12:14 AM
NCT ID:
NCT00106158
Eligibility Criteria:
Inclusion Criteria:
* Histologically proven cancer
* Confirmed NY-ESO-1 expression
* No other effective therapy available
* 4 weeks since conventional therapy before start of the current protocol
* Performance status \< 2 (ECOG scale)
* Age \> 18
* Able and willing to give written informed consent
Exclusion Criteria:
* Serious illness
* Metastatic diseases to central nervous system
* Concomitant systemic treatment with corticosteroids, anti-histaminic drugs or NSAIDs
* HIV positive
* Mental impairment that may compromise the ability to give written informed consent
* Pregnancy and breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00106158
Study Brief:
Protocol Section:
NCT00106158